Bronchial Neoplasms Clinical Trial
Official title:
Assessment of a Novel, Fast and Automatic CT-to-patient Registration Method During Navigated Bronchoscopy and Endobronchial Ultrasound Bronchoscopy (EBUS)
Bronchoscopic diagnosis and staging of lung cancer must be gentle and quick, and requires optimal sampling precision.Electromagnetic navigation systems are promising for intraoperative guiding based on maps made of preoperative CT images. Navigation accuracy depends largely on correct alignment of preoperative images to the patient´s position in space during endoscopy. In this study, the accuracy of a new fast and automatic image-to-patient registration method during the initial phase of bronchoscopy is assessed in patients referred for lung cancer investigation.
Status | Completed |
Enrollment | 26 |
Est. completion date | August 2015 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - referred to thoracic department St Olavs Hospital due to suspicion of lung cancer - informed consent Exclusion Criteria: - pregnancy |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Norway | Department of Thoracic Medicine, St Olavs Hospital | Trondheim |
Lead Sponsor | Collaborator |
---|---|
St. Olavs Hospital | Norwegian University of Science and Technology, SINTEF Health Research |
Norway,
Sorger H, Hofstad EF, Amundsen T, Langø T, Leira HO. A novel platform for electromagnetic navigated ultrasound bronchoscopy (EBUS). Int J Comput Assist Radiol Surg. 2015 Nov 28. [Epub ahead of print] — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | endoscope position (measured in millimetres from origo in the x, y and z-plane) in 3 dimensional maps from preoperative CT images | intraoperative positional data of bronchoscope or endobronchial ultrasound scope (EBUS) measured and stored in navigation system software, used for registration and navigation system accuracy calculations | 48 hours | No |
Secondary | duration of procedure | time from first entry of endoscope through vocal cords to final withdrawal of endoscope | 48 hours | No |
Secondary | patient reported satisfaction | enquiry on patients´own experience 2 hours after end of navigated bronchoscopy/EBUS procedure | 48 hours | No |
Secondary | adverse events | procedure related adverse events or unexpected incidents registrated | 48 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02909452 -
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
|
Phase 1 | |
Terminated |
NCT02050724 -
ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT
|
Phase 2 | |
Suspended |
NCT03745859 -
Evaluation of a New Open Source Virtual Bronchoscope Navigation System
|
||
Terminated |
NCT04644315 -
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
|
Phase 2 | |
Recruiting |
NCT02804100 -
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
|
N/A | |
Active, not recruiting |
NCT05241873 -
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
|
Phase 1/Phase 2 | |
Completed |
NCT03037385 -
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04862780 -
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06376084 -
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
|
||
Recruiting |
NCT03402048 -
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial
|
Phase 3 | |
Recruiting |
NCT02264210 -
Icotinib for Completed Resected IB NSCLC With EGFR Mutation
|
Phase 2 | |
Terminated |
NCT05153408 -
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
|
Phase 1 | |
Completed |
NCT01261585 -
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
|
N/A | |
Recruiting |
NCT06177925 -
A Phase â…ˇ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
|
Phase 2 | |
Completed |
NCT02897778 -
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT03516214 -
EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations
|
Phase 1 | |
Completed |
NCT02745002 -
Navigated EBUS and Functional Imaging in Lung Cancer
|
N/A |